Skip to main content
Netramark Holdings Inc. logo

Netramark Holdings Inc. — Investor Relations & Filings

Ticker · AIAI ISIN · CA64119M1059 LEI · 391200VOK8WHERIX0Q06 CSE Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 336 across all filing types
Latest filing 2023-03-02 AGM Information
Country CA Canada
Listing CSE AIAI

About Netramark Holdings Inc.

https://www.netramark.com/

Netramark Holdings Inc. develops and deploys advanced Artificial Intelligence (AI) and Machine Learning (ML) solutions specifically for the pharmaceutical industry, focusing on optimizing clinical trial design and outcomes. Its core product, NetraAI, is an AI platform powered by the proprietary Attractor AI algorithm. NetraAI analyzes complex, multimodal clinical trial datasets to uncover hidden patient correlations and causal factors, providing high clarity and explainability. The platform delivers AI-powered insights to trial sponsors, clinical research organizations, and biotechnology companies. These insights are used to inform protocol design, identify optimal patient subpopulations, determine effective dosage, enhance enrichment strategies, and improve inclusion/exclusion criteria, thereby increasing effect sizes and minimizing clinical trial risks.

Recent filings

Filing Released Lang Actions
Form of proxy - English.pdf
AGM Information Classification · 100% confidence The document is a Form of Proxy for the Annual General Meeting (AGM) of NetraMark Holdings Inc. It includes instructions for appointing a proxyholder to vote on behalf of shareholders at the AGM, details on voting for directors, appointment of auditors, and procedural notes related to the meeting. There is no financial data, management discussion, or report content; rather, it is a voting instruction document related to the AGM. This fits the definition of AGM Information (AGM-R), which covers presentations and materials shared during the AGM, including proxy forms.
2023-03-02 English
News release - English.pdf
Regulatory Filings Classification · 90% confidence The document is a press release announcing the release of a white paper by NetraMark Holdings Inc. The content focuses on describing the capabilities of their AI technology in clinical trial data analysis and the potential impact on clinical trials. It includes forward-looking statements and references to the white paper but does not contain actual financial data, regulatory filings, or detailed financial reports. The document is not an annual report, earnings release, management discussion, or any formal regulatory filing. It is a corporate announcement about a research publication and technology validation. Given the nature and length of the document (9,551 characters), it is not a brief factsheet or a short announcement of a report publication. However, it is primarily an announcement of a research white paper release, which aligns best with the category of Regulatory Filings (RNS) as a general announcement that does not fit other specific categories.
2023-02-27 English
News release - English.pdf
Regulatory Filings
2023-02-24 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings
2023-02-24 English
Interim MD&A - English.pdf
Regulatory Filings
2023-02-24 English
Interim financial statements/report – English.pdf
Regulatory Filings
2023-02-24 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.